Dextrose Monohydrate 50% Injection — FDA Drug Shortage

Current — Amphastar Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Dextrose Monohydrate 50% Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on Jan 13, 2022. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Amphastar Pharmaceuticals, Inc.
Package NDC
76329-3302-1
Dosage Form
Injection
Presentation
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)
Initial Posting
Jan 13, 2022

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.